Quote:
Originally Posted by pmax
Who are "they" when the Moderna study is still ongoing ?
Moderna Announces Publication of Results from the Pivotal Phase 3 Trial of the Moderna COVID-19 Vaccine in The New England Journal of Medicine
December 31, 2020 at 9:22 AM EST
The Phase 3 COVE study is ongoing and will continue to follow participants for two years. Additional data to be collected will include longer term safety follow-up, duration of protection against COVID-19, and efficacy against asymptomatic SARS-CoV-2 infection. Moderna is also conducting a Phase 2/3 study of the Moderna COVID-19 vaccine in adolescents 12 to under 18 years of age. Additional studies are planned to evaluate the Moderna COVID-19 Vaccine in pregnant women, children younger than 12 years, and those in special risk groups, such as the immunocompromised.
|
You are only looking at the Phase 3 study, which started in July 2020. Moderna also "published" some preliminary information on the Phase 1 and Phase 2 subjects and their antibodies. The data was promising, with an anticipated loss of only 10% of antibodies per year. The sample is small, which is why it is preliminary information.
I am in the phase 3 and will continue to be monitored for 2 years to check antibody levels. Admittedly, I'm only entering this phase now, as I was Placebo for the main phase 3 efficacy study.